MGC Pharmaceuticals Limited
MGCLF · OTC
12/30/2023 | 6/30/2023 | 12/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,076 | -$9,941 | -$10,882 | -$12,909 |
| Dep. & Amort. | $655 | $379 | $161 | $165 |
| Deferred Tax | $0 | -$4,358 | $0 | -$697 |
| Stock-Based Comp. | $0 | $1,719 | $938 | $40 |
| Change in WC | $0 | $1,881 | $0 | $328 |
| Other Non-Cash | -$175 | $5,089 | $4,289 | $6,308 |
| Operating Cash Flow | -$7,906 | -$5,231 | -$6,754 | -$6,765 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$17 | $46 | -$236 | -$321 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $26 | $770 | $1,013 |
| Investing Cash Flow | -$17 | $72 | $534 | $691 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14,281 | $2,769 | $0 | -$13 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14,160 | $4,277 | $5,456 | -$75 |
| Financing Cash Flow | $14,160 | $4,277 | $5,456 | -$75 |
| Forex Effect | $5 | -$21 | $11 | -$30 |
| Net Chg. in Cash | $6,242 | -$894 | -$753 | -$6,178 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $240 | $1,134 | $1,886 | $8,065 |
| End Cash | $6,482 | $240 | $1,134 | $1,886 |
| Free Cash Flow | -$7,923 | -$5,185 | -$6,990 | -$7,086 |